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Abstract
Spherulites are multilamellar vesicles consisting of concentric shells that can encapsulate small organic molecules or macromolecules. We
investigate the possibility of targeting neutral spherulites to adherent culture cells by functionalizing their surface with RGD-containing
ligands. The strength and specificity of association of RGD spherulites with several cell lines (EAhy 926 endothelial cell line, human
umbilical vein endothelial cell (HUVEC) and human osteoprogenitor (HOP) primary cells) was studied, and the molecular interaction of
RGD spherulites with the EAhy 926 cell surface was investigated. We show that, after binding to cells, spherulites are internalized.
D 2002 Elsevier Science B.V. All rights reserved.
Keywords: Targeting; Controlled release; RGD
1. Introduction
Spherulites are a kind of lipidic vesicles, multilamellar up
to the center and obtained from pure lipidic lamellar phases
submitted to a shear mechanical constraint [1,2]. In their
structure of concentric lipid membranes of 4 nm thickness,
separated by 4-nm-thick water layers, they can encapsulate
large amounts of small organic molecules, proteins or DNA
macromolecules [3,4]. They have proved to be promising
biological vectors for controlled delivery in vitro [5] as well
as in vivo [6,7]. However, the mechanism of delivery is still
poorly understood and has to be improved. As previously
shown [8], neutral spherulites do not interact with cells
whereas cationic ones adhere strongly to the cell surface.
Cationic vectors are well known to associate easily with
cells and are largely used for in vitro DNA delivery [9].
However, for in vivo vectorization purposes, cationic vec-
tors are difficult to use because of their nonspecific inter-
action with all kind of cells and with serum proteins [10].
More specific interactions with cells can be obtained with
targeted neutral vectors using molecular recognition: the
surface of the vector is functionalized with specific ligands
able to bind receptors at the surface of the cells of interest, in
vitro [11,12] and in vivo [13]. In such a strategy, the
targeting ligands should be chosen specifically for each
therapeutic goal. In a first attempt to study targeted inter-
action of spherulites with cells, we use the Arg-Gly-Asp-
containing (RGD) ligand and integrin receptor as a molec-
ular recognition model. RGD ligands provide a good model
as they are both simple to synthesize chemically and quite
ubiquitous, allowing comparative studies on different cell
types. Moreover, they constitute useful molecular addresses
in vivo, as proved by the numerous RGD-motifs in proteins
from pathogens, like adenoviruses [14], snake venoms or
bacteria [15]. RGD mimics may also have direct therapeutic
effects: they are presently under study as antithrombotic
agents [16] or for therapeutic targeting against bleeding and
osteoporosis [17].
Here, we describe the interaction of neutral RGD func-
tionalized spherulites with adherent cultured cells. We first
investigate the strength and specificity of the interaction,
then the interaction at a molecular level, and finally we
present preliminary results on the cellular capture of the
associated spherulites.
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2. Materials and methods
2.1. Chemicals
We have used synthetic lipopeptides of the form (Palm)2-
spacer-address, with the peptidic sequence GRGDSP as
address, or GRGESP as a control. Lipopeptides R5:
(Palm)2Lys-(CH2)3O-(C2H4O)2-(CH2)3N-CO-(CH2)3CO-
Tyr-Gly-Arg-Gly-Asp-Ser-Pro-NH2 and R5E: (Palm)2Lys-
(CH2)3O-(C2H4O)2-(CH2)3N-CO-(CH2)3CO-Tyr-Gly-Arg-
Gly-Glu-Ser-Pro-NH2 were synthesized by solid phase
peptide synthesis and purified by reversed phase HPLC
following lipopeptide specific methods [18]. The compet-
itive peptide GRGDSP (H-Gly-Arg-Gly-Asp-Ser-Pro-NH2)
was provided by Bachem, France. The fluorochromes cal-
cein and propidium iodide (PI) were provided by Sigma,
France, Rhodamine 6G-dihexadecylphosphatidylethanol-
amine (Rhd-DHPE) and Hoechst 33342 by Molecular
Probes, OR, USA. Phosphatidylcholine (PC) from soya
S100 was provided by Lipoid, France. The lipids 1-mono-
oleylglycerol (MO) and dioleoyltrimethylamminopropane
(DOTAP) by Sigma.
2.2. Preparation of control, cationic, RGD and RGE
spherulites
The lipidic mass composition of spherulites were: PC/
MO 95:5 (control), PC/MO/DOTAP 85:5:10 (cationic), PC/
MO/R5 85:5:10 (RGD) and PC/MO/R5E 85/5/10 (RGE).
For RGD spherulites of different RGD concentrations, the
mass ratio of R5 was varied, keeping the total mass
proportion of PC +R5 equal to 95%. When indicated,
Rhd-DHPE in methanol solution was added (weight ratio
Rhd-DHPE/lipids = 0.1%). The mixture of lipids and sur-
factants was dissolved in a small amount of hot ethanol
(45 jC), precipitated in excess distilled water and lyophi-
lized. They were then hydrated with a calcein 1 mM pH 5.6
aqueous solution at a final mass ratio of water/lipids = 48:52.
The mixture was stored in the dark at room temperature for a
few hours. It was then sheared in a cone-shaped microtube
by manual rotation of a closely fitted pestle. It was imme-
diately suspended in sterile PBS pH 7.4 buffer and used for
contact with cells. The spherulites in suspension have a mean
diameter of about 200 nm, as measured by static and
dynamic light scattering (data not shown), with a character-
istic repeating distance between bilayers of around 8 nm
(measured by X-ray [3]). A simple geometrical calculation
leads to a value of around 10% of the lipids belonging to the
external lipid monolayer.
The fluorescence intensity IFi (493/510 nm) of a dilution
of the spherulite sample i (104 mg/l of lamellar phase) was
measured in a pH 7.4 buffer (Tris 10 mM, EDTA 0.5 mM)
supplemented with Co2 + (CoCl2 1 mM) on a SPEX Fluo-
roMax fluorometer (Jobin Yvon, UK). Co2 + ions quench the
fluorescence of free calcein only, as diffusion of Co2 +
through the membranes of spherulites is very slow. The
proportion of free calcein in the suspension due to leakage
was usually low, between 5% and 30%. The relative
spherulite fluorescence qi of sample i was calculated as
qi = IFi/IF0, where IF0 is the highest fluorescence measured
in a series (usually cationic spherulites).
Although large differences in inner fluorescence of
spherulites were observed, calcein proved to be the best
fluorescent marker for cytometry analysis. Indeed, rhodamin
fluorescence could not be excited with the blue laser of the
cytometer, and other green fluorescent probes (fluorescein,
Alexafluor 488) were either less fluorescent or more sensi-
tive to chemical environment in the spherulites than calcein.
2.3. Cell culture
EAhy 926 [19] and Jurkat cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented
by 10% foetal calf serum, penicillin and streptomycin, under
CO2-enriched atmosphere. Primary human osteoprogenitor
(HOP) cells and primary human umbilical vein endothelial
cells (HUVEC) were prepared from healthy donor tissues
and cultured as described in [20,21], respectively.
2.4. Cell/spherulites contact
Before the contact experiments, cells were harvested
using trypsin and washed twice in HBSS buffer. They were
suspended in serum-free DMEM and spread at 6 105 cell/
ml, 300 Al/well on 24-well plates. Spherulites and, when
needed, the competitive peptide were added immediately.
The plates were centrifuged (400 g, 5 min, 4 jC) and
incubated at 37 jC under a CO2-enriched atmosphere for
4 h, or at 4 jC. The cell coat was then thoroughly washed,
cells were harvested in serum and phenol red free DMEM
using a micropipet and analyzed by cytometry.
For kinetic studies with RGD spherulites, cells were
spread in cytometer tubes and incubated at 37 jC under a
CO2-enriched atmosphere. After 1 h and at regular time
periods thereafter, spherulites were added in one tube, the
tube was centrifuged (400 g, 5 min, 4 jC) and further
incubated. In the end, all tubes were centrifuged as pre-
viously, cells were suspended in serum and phenol red free
DMEM using a micropipet and analyzed by cytometry.
For kinetic studies with cationic spherulites, cells were
collected in a cytometer tube maintained at 37 jC. Cationic
spherulites were added and the mixture was analyzed by
cytometry, immediately and then every minute thereafter.
The concentrated spherulites in the suspension induced a
constant added fluorescence that was measured with control
spherulites and subtracted.
2.5. Cytometry
Cytometric measurements were carried out on a FACS-
can, Becton Dickinson, NJ, USA. PI (500 Ag/l) was added
to the samples before analysis, mean cell fluorescence of
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living cells was measured as the median fluorescence of the
PI-negative cellular events. The cell fluorescence data had to
be corrected because of large differences in inner fluores-
cence of spherulites: in particular, RGD spherulites were
usually less fluorescent than cationic and control spherulites
by a factor of 2 to 5 (this could be due to differences in
spherulites inner pH in the presence of lipopeptide [22], or
to interactions of RGD peptides with calcein in the con-
centrated inner aqueous phase). The mean cell fluorescence
of untreated cells FC0 was subtracted from mean cell
fluorescence FCi of sample i to obtain the cell fluorescence
due to calcein; then the difference was renormalized by the
inner fluorescence of spherulites (see Section 2.3) for the
calculation of the corrected cell fluorescence FC*: FCi*=
(FCi FC0)/qi. FC* is thus proportional to the mean num-
ber of bound spherulites per cell. FC* values correlated
qualitatively well with the average number of captured
spherulites per cell observed by fluorescent microscopy.
2.6. Cell fluorescence data analysis
Data were analyzed in the following model: spherulites
Oi of sample i «react» with adhesion sites S on cells to
become bound spherulites B. The overall concentrations of
those species are oi, s and b, respectively, their respective
initial values are o0, s0 and 0, and oi is considered constantly
equal to o0 because Oi is introduced in a large excess
(4 10 10 M= 2.4 1011 sph/ml vs. 106 cell/ml). Reaction
rates of the reaction and reverse reaction are ki and k,
respectively, with Ki= ki/k the thermodynamic equilibrium
constant of the reaction.
Oi þ S ! B ð1Þ
db=dt ¼ kio0ðs0  bÞ  kb ð2Þ
then
b ¼ blð1 expðt=sÞÞ ð3Þ
where
bl ¼ s0ðKio0Þ=ð1þ Kio0Þ ð4Þ
s ¼ kio0 þ k ð5Þ
The mean cell fluorescence is proportional to b, therefore
the cell fluorescence vs. time data were fitted with Eq. (3) to
determine s and ki from Eq. (5), which can be approximated
to sc ki o0 if o0 is large enough. The affinity constant Ki of
spherulites for the cell surface is estimated using the same
model in the long time limit, where b= bl. The fluores-
cence vs. spherulite concentration (o0) data were fitted with
Eq. (4) to determine Ki.
2.7. Fluorescence microscopy
Cells were harvested using trypsin and washed twice in
HBSS buffer. They were suspended in serum-free DMEM
and spread at 106 cell/ml on glass coverslips. Spherulites
labeled with calcein and Rhd-DHPE were added immedi-
ately. The plates were incubated at 37 jC under CO2-
enriched atmosphere. The cell coat was then thoroughly
washed, covered with phenol red free DMEM and observed
by fluorescence microscopy (Nikon Eclipse TE300 with
CCD C2400-57 Hamamatsu camera or Zeiss Axiovert 100
M with Princeton MicroMax 5 MHz Interline 1300Y
camera and Universal Imaging software).
3. Results
3.1. Neutral RGD spherulites adhere to the surface of
EAhy 926 cultured cells
The association of fluorescent spherulites to cells was
measured as the increase in cell fluorescence after incuba-
tion of cells with spherulites. Neutral spherulites grafted
with RGD peptides of sequence GRGDSP were compared
to neutral ungrafted (control) and cationic spherulites. After
4 h of contact at 37 jC, cells incubated with RGD (Fig. 1B)
or cationic spherulites (Fig. 1A) (4 10 10 M, i.e.
Fig. 1. Fluorescence microscopy pictures (filters 485/515 nm) of EAhy 926
cells after 4 h contact with cationic (A) or RGD spherulites (B). Control
cells and cells treated with control spherulites were not fluorescent.
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5 10 4 g of lipids/ml) were highly labeled, whereas EAhy
926 cells incubated with control spherulites showed a very
faint fluorescence (not shown). The increase in fluorescence
of living cells after incubation with spherulites was quanti-
tatively measured by flow cytometry (Fig. 2A-D). Taking
into account the lower fluorescence intensity of RGD
compared to cationic spherulites (see Section 2.3), the
normalized cell labeling FC* with RGD and cationic spher-
ulites were similar (Fig. 2E). Note, however, that the cell
fluorescence distribution is more heterogeneous for cells
incubated with RGD than with cationic spherulites. We will
come back to this point later on.
Data were highly reproducible when cell–spherulite
association experiments were carried out together: all meas-
urements were made on a doublet of samples and both
results were usually within 10% error. However, quantita-
tive FC* results varied from one day to another up to a
factor of 10 for the same spherulite sample, depending on
the cell preparation. These sharp variations were probably
due to differences in the growth stage of the cells and/or the
condition of their surface after trypsinization, in particular
the extent of extracellular matrix digestion. Nevertheless,
the FC* ratios between different spherulite types were kept
roughly constant from a series of experiments to another.
Over seven independent experiments, cell labeling FC* by
RGD spherulites was 10F 5 times higher than labeling by
control spherulites and of the same order of magnitude as by
cationic spherulites (1.8F 1 fold lower on average). Cell
labeling by the free calcein dye was always low (same or
lower than by control spherulites, data not shown).
3.2. Kinetics of interaction
The kinetics of interaction of cationic and RGD spher-
ulites with EAhy 926 cells was investigated by flow
cytometry at 37 jC (Fig. 3). Cationic spherulites associated
to cells in a few minutes (characteristic time of about 2 min).
Fig. 3. Renormalized mean cell fluorescence of EAhy 926 cells incubated
with cationic (triangles) or RGD (circles) spherulites at 37 jC. The insert is
a magnification of the data concerning cationic vesicles. The lines
correspond to the best fit of FC0 +B(1 exp( t/s)), where s= 154 s
(triangles, R= 0.94) and s= 1500 s (circles, R = 0.96).
Fig. 2. On the left: cytometry data, represented in a green fluorescence (FL1) vs. forward scattering (FSC= size parameter) plot, of EAhy 926 cells after 4 h of
contact with control buffer (A), control spherulites (B), cationic (C) and RGD (D) spherulites (4 10 10 M) at 37 jC. Grey spots are events corresponding to
living cells, dark grey spots to dead cells, black spots to cell fragments or dust. On the right (E): corrected cell fluorescence FC* corresponding to the cytometry
data presented on the left. Intervals represent the width of the fluorescence distribution of living cells.
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In contrast, the association of RGD spherulites to EAhy 926
cells took place in a longer time (about 20 min). The
corresponding rate constants of adhesion were fitted accord-
ing to Eq. (3), giving, respectively: kcat = 2 107 M 1 s 1
and kRGD = 2 106 M 1 s 1. Note that the kinetic experi-
ments could not be performed in the same conditions for
both kind of adhesive spherulites: for cationic spherulites,
the measurements were made on one cell sample without
centrifugation, whereas, with RGD spherulites, one cell
sample was used for each time to avoid cell death during
the long waiting periods between measures. Further, cocen-
trifugation of RGD spherulites and cells was necessary to
obtain good interaction, whereas cocentrifugation could not
be performed on cationic spherulites and cell samples
because of the rapid association. We have checked that,
after 4 h, the cell labeling by cationic and RGD spherulites
remained constant for at least 1 day (data not shown).
3.3. Affinity constant of RGD-grafted and cationic
spherulites
The affinity of spherulites for the EAhy 926 cells has been
evaluated by a fluorescence method for different types of
spherulites, the quantitative binding constants have been
extracted using a thermodynamic model of association of
Fig. 5. Corrected mean cell fluorescence FC* of EAhy 926 cells incubated 4
h at 37 jCwith spherulites graftedwith increasing concentration of GRGDSP
ligands. Different signs correspond to five gathered independent experi-
ments. The surface concentration C of RGD is expressed in number of RGD
peptides per 200 nm2 of spherulite surface, where 200 nm2 is the approximate
area of an integrin molecule [23]. The line (the best linear fit: FC*= 9.44C,
R = 0.889) is meant as a guide for the eye. The arrow indicates the RGD
concentration used in the other experiments (10% in mass of lipids).
Fig. 4. Cell fluorescence of living cells incubated 4 h at 37 jC with growing concentrations o0 of cationic or RGD spherulites. The curves represent three
independent trials (same trial on both plots). The solid line is the best fit to equation as0 (Kio0)(1 +Kio0) to determine Ki values: Kcat = 1.4 1010 M 1
(circles), 2.5 109 M 1 (squares), 2.0 109 M 1 (triangles) for cationic and KRGD = 1.7 1010 M 1 (circles), 1.3 1010 M 1 (squares), 1.2 1010 M 1
(triangles) for RGD spherulites.
Fig. 6. Mean corrected cell fluorescence FC* of EAhy 926 cells after 4 h of
incubation with control (squares), cationic (triangles) or RGD (circles)
spherulites (4 10 10 M) and a soluble competing peptide GRGDSP in
growing concentration.
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free spherulites to association sites on the cell surface (Fig.
4). Depending on the experiment, the level of maximal cell
fluorescence changed, as previously noted. However, the
characteristic concentration of spherulites needed for optimal
association was conserved. From this measured value, we
deduced the mean association constants Kcat=(4.2F 2.4)
109 M 1 and KRGD=(2.3F 0.9) 1010 M 1 for cationic and
RGD spherulites, respectively. For these cells, the neutral
RGD spherulites have a slightly better affinity for the cell
surface than cationic spherulites. These association constants
should be considered carefully as they have been established
on cellular material, where both availability and activity of
integrins are cell regulated. Moreover, if some spherulites
had been endocytosed, the K values would be overestimated.
The cocentrifugation of cells and vectors used to help contact
should also increase association constants. In all experiments
described below, the concentration in spherulites was set to
4 10 10 M, i.e. 0.5 g/l of lipids. This concentration,
corresponding to the beginning of the plateau, provided
optimized adhesion sensitivity and minimized cell death,
particularly with cationic spherulites.
The labeling of EAhy 926 cells by RGD spherulites was
then measured as a function of RGD ligand concentration on
the spherulite surface. The molar ratio in RGD-grafted lipids
in the membranes of the lamellar phase was varied from
0.8% to 15%, corresponding to a mean RGD concentration
at the surface1 of 0.01 to 0.2 RGD ligands/nm2. This
concentration is to be compared to the concentration in
RGD binding sites on the counterpart cell surface. The outer
part of integrin molecules, on which the unique RGD
binding site is situated [23], is a globular domain of 12–
15 nm in diameter according to electronic microscopy
studies [23,24]. Therefore, each integrin molecule occupies
an estimated area of 200 nm2, which correspond to a
maximal surface concentration in binding sites on the cell
membrane of 1 per 200 nm2 if the integrins were tightly
clustered. On Fig. 5, the GRGDSP ligand density at the
spherulite surface is expressed in number of ligands per 200
1 Spherulites have a mean diameter of about 200 nm; the density of the
lamellar phase (52% lipids in mass) is very close to 1; the mean molecular
weight of the major lipid component, PC, is approximatively 800 g/mol.
Fig. 7. Corrected cell fluorescence FC* of Jurkat, HOP, HUVEC and EAhy
926 cells incubated 4 h at 37 or 4 jC with control (white bars), cationic
(gray bars), RGD (striped bars) or RGE (squared bars) spherulites
(4 10 10 M). Corrected cell fluorescence FC* values were renormalized
for each cell type to gather all data on the same plot (labeling by control
spherulites at 37 jC was set to 2).
Fig. 8. Superposed fluorescence microscopy pictures of HOP cells
incubated 24 h with RGD spherulites. Spherulites were labeled with
calcein (green) in the water phase and Rhd-DHPE (red) within the lipids,
the nucleus was labeled by Hoechst 33342 (blue).
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nm2. The plot, gathering results from five independent
experiments, shows a strong and constant dependence: the
affinity of RGD spherulites is shown to grow sharply with
ligand density, although the ligands are provided in large
excess. The standard surface concentration in RGD ligands
onto spherulites used in previous and forward experiments
is indicated by an arrow in Fig. 5. The slope of the log/log
plot is about 1, indicating a rough proportionality between
the adhesion constant and the ligand concentration.
3.4. The adhesion of RGD spherulites is ligand-specific
If the association of RGD spherulites to cells were due to
specific molecular recognition of the RGD ligands, it should
be inhibited in the presence of a large excess of free RGD
peptides. To check this, the cells were incubated with
spherulites and a competing RGD peptide of sequence
GRGDSP in increasing concentration. As shown in Fig. 6,
the labeling of cells incubated with control or cationic
spherulites was not disturbed by the competing peptide
whereas the labeling of cells incubated with RGD spher-
ulites was reduced by a factor of 3. The IC50 value could be
estimated to 12F 5 AM (two independent measurements),
for a concentration of 2.8 AM RGD peptides grafted on 0.4
nM spherulites.
As another specificity control, we built grafted spheru-
lites where the grafted GRGDSP peptide ligand was
replaced by a GRGESP ligand (named RGE spherulites in
what follows). EAhy 926 cells incubated with RGE spher-
ulites were labeled nearly as little as cells incubated with
control spherulites (Fig. 7). Over five independent experi-
ments, the mean RGD/RGE FC* labeling ratio was 6F 4.5
whereas the mean RGE/control ratio was only 2F 0.5. The
molecular recognition of the RGD-grafted ligands is there-
fore responsible for the association of RGD spherulites to
cells.
3.5. RGD targeting is tissue-specific
We also investigated the adhesion specificity of RGD
spherulites in respect to cells from different types of tissues.
Different cell types were used: EAhy 926 and Jurkat perma-
nent cell lines and HUVEC and HOP primary cells. Adhe-
sion of RGD, RGE, cationic and control spherulites was
compared (Fig. 7) after 4 h contact at 37 jC. The FC* values
of cell labeling are not to be compared from one cell type to
the other as the very different cell size, metabolism, mor-
phology and self-fluorescence affect greatly the cytometric
measure. Only the relative association ability of grafted and
ungrafted spherulites on each cell type should be compared.
Cell labeling data were therefore renormalized to display the
results in the same plot (FC* for control spherulites at 37 jC
was set to 2). The renormalization was chosen so that the
labeling data in Fig. 7 correlated qualitatively with the
relative fluorescent labeling of the different cell types, when
compared by fluorescence microscopy.
Cationic spherulites associated well with all cell types. In
contrast, RGD spherulites associated only with adherent
cells, namely EAhy 926, HOP and HUVEC. Note that for
the latter, RGD spherulites bound with a particularly high
affinity compared to cationic spherulites. This association
was further shown to be specifically due to the molecular
recognition of the GRGDSP ligand by comparing to the
RGE control. The nonadherent Jurkat cells only associated
with cationic spherulites and not with neutral ones, whether
RGD or RGE grafted, or ungrafted.
3.6. RGD spherulites are internalized by cultured cells
The association of spherulites to EAhy 926 cells was
compared at 37 and 4 jC. As shown in Fig. 7, the
association of RGD and cationic spherulites was partly
inhibited at 4 jC, indicating that the association of
Fig. 9. Transmission and fluorescence microscopy pictures of a HUVEC cell incubated 4 h with RGD spherulites. Spherulites were labeled with calcein in the
water phase.
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spherulites to cells is partly due to an active process. In
preliminary experiments, evidence of internalized spheru-
lites in EAhy 926, HUVEC and HOP cells have been
obtained using fluorescence microscopy. The spherulites
were labeled with calcein as a model encapsulated drug
and with Rhd-DHPE within the lipids. Before observation,
cells were further labeled with the DNA-intercalation dye
Hoechst 33342. Fig. 8 shows HOP cells after 24 h
incubation with RGD spherulites. The fluorescent spher-
ulites are certainly inside the cell as they are cofocused
with the nucleus of the cell to which they are associated.
Internalization was further evidenced by 3D reconstruction
pictures computed from series of fluorescence pictures of
one cell stacked in depth (data not shown). Internalization
by HOP, EAhy 926 and HUVEC cells was also observed
in some cells after 7 h contact with cationic or RGD
spherulites at 37 jC.
Furthermore, in some cases, the model drug and the
lipids of internalized RGD spherulites seemed to separate
after 24 h incubation with cells, as shown in Figs. 9 and 10.
Fig. 9 shows a HUVEC cell with large intracellular vesicles
or vacuoles containing the fluorescent calcein dye initially
encapsulated into the spherulites. In these vacuoles, the
characteristic particulate shape of fluorescent spherulites
has disappeared. Such fluorescent vacuoles could not be
observed in cells incubated with free calcein. Fig. 10 shows
a EAhy 926 cell preincubated with doubly labeled RGD
spherulites for 24 h. The model drug and the lipids of
spherulites seem to be separated inside the cell as the green
and red spots are far away from each other, whereas the
Fig. 10. Superposed transmission and fluorescence microscopy picture of EAhy 926 cells incubated 24 h with RGD spherulites. Spherulites are labeled with
calcein (green) in the water phase and Rhd-DHPE (red) within the lipids. Below: fluorescence intensity along the section drawn as a blue line on the above
picture.
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spherulites associated to the cell but still on the surface (on
the left of the picture) possess both labels colocalized.
4. Discussion
4.1. RGD spherulites specific association to cells
Cationic colloids are well known to associate strongly
with cells due to electrostatic attraction to the anionic cell
surface [25], whereas neutral colloids do not interact with
cells [8]. These provide positive and negative controls,
respectively, for the study of targeted neutral spherulites
with cells (Fig. 2). In comparison with these controls, RGD
spherulites prove to associate in a large amount with
endothelial EAhy 926 cells in vitro. This interaction is
due to the molecular recognition of the grafted RGD
ligands, as proved by the displacement assay (Fig. 6) and
the strong sequence-dependence of the association (Fig. 7).
Unfortunately, a displacement assay with integrin antibody
was not possible because the RGD-binding integrins are
numerous and redundant. Nevertheless, this binding is also
certainly specific of the molecular recognition by active
integrins as nonadherent cells, such as Jurkat cells, do not
bind RGD spherulites (Fig. 7). Furthermore, active integrins
should be free to provide association. Indeed, it was
observed that RGD spherulites labeling of adherent cells
was sharply reduced when the cells were already adhering to
the culture dish.
As illustrated in Fig. 2D, the fluorescence distribution of
RGD spherulites labeled EAhy 926 cells was particularly
broad, while the fluorescence of cell populations incubated
with cationic spherulites was more homogeneous. The
labeling heterogeneity was even stronger when cells were
concentrated in the sample and formed clusters. Actually,
cell adhesion varies during cell cycle and with the growth
rate, itself regulated by contacts with neighbor cells and the
extracellular matrix [26]. The availability of integrins for
RGD spherulite binding should then depend sharply on
cell–cell and cell–matrix associations. The binding of one
RGD spherulite could even increase the probability of
binding of a second one, which would result in a broad
cell labeling distribution as observed. Such complex regu-
lation does not exist in the case of cationic spherulites,
where only electrostatic interactions with the negatively
charged glycocalyx are involved.
4.2. Interaction between RGD spherulite and cell surface
The affinity constant, KRGD, of RGD spherulites for
integrins at the cell surface can be compared to the affinity
constant, K1, of one RGD ligand for integrins. Such a
constant has been determined for integrins of the cell surface
(NRK cell line) and the peptide GRGDSP to K1 = 3.3 103
M 1 by Pierschbacher and Ruoslahti [27]; and for in vitro
isolated aIIbh3 integrins and the peptide GRGDS by Erb et
al. [24] to be K1 = 5 105 M 1. The affinity of the free
peptide GRGDSP for the cell surface of EAhy 926 cells is
then expected to be quite low, with K1c10
4 M 1. There-
fore, the strong measured affinity of RGD spherulites for
cells (Knc 2 1010 M 1) should be due to the coopera-
tivity of several RGD ligands bound to several integrins.
Thanks to cooperativity, the grafted RGD ligand has a better
affinity for cells than the free ligand, as shown in Fig. 6 (a
concentration in free RGD ligand of IC50 = 12F 5 AM was
needed to displace the association of 2.8F 0.5 AM RGD
ligands grafted on spherulites).
We can now model quantitatively the strong affinity of a
colloidal RGD spherulite for cells. The cooperative associ-
ation of multivalent ligands to multivalent receptors is
predicted by a classic thermodynamic model as follows
(for a review, see Ref. [28]). We compare the association
constants Kn of a n-valent ligand Ln with a n-valent receptor
Rn, and K1 of the same monovalent ligand L1 with the
monovalent receptor R1. Ki is determined from the standard
difference of free enthalpy, DrGi, in the association process
as RT ln(Ki) =DrGi =DrHi T DrSi, where i is 1 or n for
the mono- and n-valent processes, respectively. The stand-
ard difference of enthalpy, DrHn, in the n-valent association
process can be evaluated as the sum of the n standard
differences of enthalpy, DrH1, in the n individual mono-
valent association processes: DrHnc nDrH1. The standard
differences in entropy, DrSi, in the monovalent and n-valent
association processes are negative and should not be very
different, as 1 species is made from 2 in both cases:
DrSncDrS1. Furthermore, as the ligand is supposed to
have a quite good affinity for the receptor, TDrS1 should
be small compared to DrH1. We then obtain between Kn and
K1 the following classical relationship: Knc (K1)
n. From
the KRGD =Kn value measured in this paper and K1 values
cited above, the expected number, n, of RGD/integrin links
per spherulite is consequently between 2 and 3.
This value is quite low compared to the expected valency
of RGD spherulites. Indeed, in the expected contact zone
between a locally planar cell surface and a spherulite (200
nm in diameter), only RGD ligands present in a disc of 40
nm diameter could «touch» the cell surface because of the
short 2.8 nm spacer linking them to the spherulite. Integrins
are large molecules, with a cylindrical shape of 12 to 15 nm
in diameter [23]. In the optimal contact configuration, we
could then expect 10–15 RGD–integrin bonds between
spherulite and cell surface and a far larger association
constant, KRGD. Further, as shown in Fig. 5, the affinity of
RGD spherulites for cells sharply depends on the ligand
concentration at the surface of the spherulite, while ligands
are already in large excess: in the usual case indicated by the
arrow in Fig. 5, 12 GRGDSP ligands face one integrin on
the cell. According to the previous model, however, the
large excess of RGD ligands should saturate the available
receptors, and KRGD should not depend on RGD ligand
density anymore. Thus, our data show substantial discrep-
ancies to the classical thermodynamic model. Such discrep-
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ancies have been usually recorded in multivalent association
processes [28].
Though this contradiction is not yet properly understood,
we propose several explanations to the need for such a large
excess of RGD ligands for efficient binding (Fig. 11). First
an extra barrier compared to the free peptide/receptor
association could come from the colloidal nature of spher-
ulites. Indeed, the ligand must meet membrane receptors
embedded under the glycocalyx (in comparison, cationic
vectors associate directly with the anionic glycocalyx). The
repulsion of the spherulite by this thick gel would reduce the
chance of ligand–receptor meeting as well as the stability of
the bond [29]. The cocentrifugation of spherulites and cells,
important to obtaining high association, could reduce this
repulsion to some extent. Second, for multivalent associa-
tion, a spherulite should encounter several integrins simul-
taneously. Indeed, if a spherulite meets only one integrin,
the one bond formed would have a short life time (t1/2c 20
As, estimated from K1 reported in Refs. [24,27]), too short
for other integrins to diffuse towards the spherulite (the
integrin diffusion coefficient D = 7 10 9 cm2 s 1 [24]
corresponds to a diffusion rate of c 100 nm in 10 ms).
RGD spherulite binding should then be a rare event, result-
ing in hindered binding kinetics. Indeed, RGD spherulite
association proved to be slow, compared to cationic spher-
ulites (Fig. 3). Cationic spherulites association to cells is
probably diffusion limited as the measured binding time (2
min) is very close to the Brownian collision time with cells
(c 30 s). In contrast, RGD spherulites associate 10 times
slower, even with cocentrifugation.
The classical thermodynamic model can then be reinter-
preted in several aspects: the enthalpy of association of
individual grafted ligands is expected to be lower than that
of free ligands; therefore, the valency n determined from the
law Knc (K1)
n should be underestimated. Further, the
association process would be increasingly slow as the most
stable n valency is high, so that the equilibrium state should
eventually never be obtained. The apparent equilibrium state
would be defined by kinetic parameters, resulting possibly
in sharp concentration dependencies as seen in Fig. 5.
4.3. Capture and internalization of cell associated
spherulites
The spherulite association to cells is partly active, as
shown by its temperature dependence (Fig. 7). The active
capture probably corresponds to endocytosis, as previously
evidenced on liposomal systems [30] and DNA–cationic
lipids complexes [31]. Indeed, in a preliminary study,
internalization of RGD and cationic spherulites could be
observed on EAhy 926, HUVEC and HOP cells after a few
hours of incubation. It is evidenced in Fig. 8, as the
fluorescent spots in the cell are cofocused with the nucleus.
Internalization was confirmed by 3D reconstruction of cells
from stacked fluorescence pictures (data not shown). In
EAhy 926 and HOP cells preincubated 4–24 h with cationic
or RGD spherulites, the spherulite fluorescent labels kept
their particulate shape. They were spread into the cytoplasm
and never came into the nucleus.
In some HUVEC cells incubated for 4 h with the vectors,
internalized RGD spherulites seemed to release their content
as the initially encapsulated calcein was present in large
inner vacuoles (Fig. 9), where the characteristic spot shape
of spherulites were no longer seen. In EAhy 926 cells
incubated for 24 h with doubly labeled RGD spherulites,
the lipid and water components of internalized spherulites
seemed to separate (Fig. 10), whereas noninternalized
spherulites kept intact. After adhesion to the cell surface,
RGD spherulites would then be endocytosed and disaggre-
gated.
5. Conclusion
In a RGD-integrin recognition model, we have shown
that neutral spherulites can stick efficiently to the cell
surface without electrostatic interactions if provided with
ligands of cell surface receptors. The interaction is strong
and highly specific of the molecular recognition of the
ligand, thanks to a cooperative interaction of several RGD
ligand–integrin pairs between spherulite and cell. Although
it proves as efficient as cationic association, the RGD-
specific association process is more complex, as in this case
a limited number of ligands must encounter a limited
number of receptors to provide interaction. Good binding
requires a large excess of spherulite-bound ligands, but it
allows a large number of spherulites to bind to one cell.
Probably, the low binding affinity of the GRGDSP ligands
is here compensated by the great concentration of integrin
receptors on adherent cells (integrins are 10 to 100 times
more frequent than other kinds of membrane receptors [23]).
In other recognition systems, a better ligand receptor affinity
(antibodies, hormones. . .) should reduce the need of so
Fig. 11. A great excess of RGD ligands (triangles) compared to integrins
(Y-shaped membrane proteins) is needed to ensure good association of
RGD spherulites to cells.
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many ligands and receptors. On the other hand, a low
affinity targeting system could provide better selectivity,
as only cells possessing a sufficient level of receptor
expression would capture the vectors, even if the receptor
is present in many tissues. This could provide a new strategy
to target cancer cells overexpressing ubiquitous nutrient
receptors as LDL or transferrin receptors.
As shown in our preliminary results, spherulites are
internalized after adhesion to the cell surface and seems to
release their content inside the cell. The way of internal-
ization and the possible role of targeting in this process are
still to be properly determined. The use of targeted spher-
ulites for drug delivery in a therapeutically relevant model is
already under study.
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